Combined structure-based drug design approaches and ADME analysis for the study of novel antiparkinsonian agents.

Simple item page
dc.contributor.authorMettai, Merzaka
dc.contributor.authorDaoud, Ismail
dc.contributor.authorMelkemi, Nadjib
dc.contributor.authorMesli, Fouzia
dc.date.accessioned2025-04-09T18:30:16Z
dc.date.available2025-04-09T18:30:16Z
dc.date.issued2022-10-23
dc.identifier.urihttp://dspace.univ-oeb.dz:4000/handle/123456789/21677
dc.language.isoen
dc.publisherUniversity of Oum El Bouaghi
dc.subjectParkinson's disease; 4-( benzyloxy) phenyl and biphenyl-4-yl derivatives; Molecular docking; Molecular dynamics; ADME prediction.
dc.titleCombined structure-based drug design approaches and ADME analysis for the study of novel antiparkinsonian agents.
dc.title.alternativeA DFT investigation and molecular docking prediction against obesity
dc.typeArticle
Files
Original bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
Combined structure-based drug design approaches and ADME analysis for the study of novel antiparkinsonian agents. .pdf
Size:
371.3 KB
Format:
Adobe Portable Document Format
Download
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description:
Download
Collections
1er Congrès International sur les Innovations dans la Chimie à visée Thérapeutique (1’ICTA 2022) 23 et 24 Octobre 2022